Zhejiang Nhu Co Ltd - Asset Resilience Ratio
Zhejiang Nhu Co Ltd (002001) has an Asset Resilience Ratio of 4.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Zhejiang Nhu Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2025)
This chart shows how Zhejiang Nhu Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Nhu Co Ltd (002001) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Nhu Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002001 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.36 Billion | 4.97% |
| Total Liquid Assets | CN¥2.36 Billion | 4.97% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Nhu Co Ltd maintains only 4.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Nhu Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Nhu Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Bausch Health Companies Inc
TO:BHC |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.15% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Hainan Haiyao Co Ltd
SHE:000566 |
Drug Manufacturers - Specialty & Generic | 3.27% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Zhejiang Nhu Co Ltd (2003–2025)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Nhu Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.75% | CN¥2.17 Billion ≈ $317.29 Million |
CN¥45.61 Billion ≈ $6.67 Billion |
+4.75pp |
| 2024-12-31 | 0.00% | CN¥745.82K ≈ $109.14K |
CN¥42.99 Billion ≈ $6.29 Billion |
-0.44pp |
| 2023-12-31 | 0.44% | CN¥173.06 Million ≈ $25.32 Million |
CN¥39.16 Billion ≈ $5.73 Billion |
-1.44pp |
| 2022-12-31 | 1.88% | CN¥720.31 Million ≈ $105.40 Million |
CN¥38.27 Billion ≈ $5.60 Billion |
-1.72pp |
| 2021-12-31 | 3.60% | CN¥1.25 Billion ≈ $183.02 Million |
CN¥34.72 Billion ≈ $5.08 Billion |
+0.84pp |
| 2020-12-31 | 2.76% | CN¥852.23 Million ≈ $124.71 Million |
CN¥30.90 Billion ≈ $4.52 Billion |
-2.12pp |
| 2019-12-31 | 4.87% | CN¥1.40 Billion ≈ $204.86 Million |
CN¥28.72 Billion ≈ $4.20 Billion |
+3.05pp |
| 2018-12-31 | 1.82% | CN¥400.00 Million ≈ $58.53 Million |
CN¥21.93 Billion ≈ $3.21 Billion |
-0.10pp |
| 2017-12-31 | 1.92% | CN¥350.00 Million ≈ $51.22 Million |
CN¥18.18 Billion ≈ $2.66 Billion |
+1.92pp |
| 2016-12-31 | 0.00% | CN¥95.56K ≈ $13.98K |
CN¥11.41 Billion ≈ $1.67 Billion |
-0.01pp |
| 2015-12-31 | 0.01% | CN¥1.26 Million ≈ $183.77K |
CN¥9.72 Billion ≈ $1.42 Billion |
-1.96pp |
| 2014-12-31 | 1.97% | CN¥180.00 Million ≈ $26.34 Million |
CN¥9.12 Billion ≈ $1.34 Billion |
+1.93pp |
| 2013-12-31 | 0.04% | CN¥3.65 Million ≈ $534.81K |
CN¥8.56 Billion ≈ $1.25 Billion |
+0.01pp |
| 2012-12-31 | 0.03% | CN¥2.42 Million ≈ $354.27K |
CN¥7.84 Billion ≈ $1.15 Billion |
+0.03pp |
| 2011-12-31 | 0.01% | CN¥390.56K ≈ $57.15K |
CN¥7.15 Billion ≈ $1.05 Billion |
-0.03pp |
| 2010-12-31 | 0.03% | CN¥2.00 Million ≈ $292.07K |
CN¥6.15 Billion ≈ $900.40 Million |
+0.03pp |
| 2009-12-31 | 0.01% | CN¥268.30K ≈ $39.26K |
CN¥4.21 Billion ≈ $616.02 Million |
0.00pp |
| 2003-12-31 | 0.01% | CN¥100.00K ≈ $14.63K |
CN¥1.05 Billion ≈ $153.86 Million |
-- |
About Zhejiang Nhu Co Ltd
Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, rumi… Read more